Blockchain Registration Transaction Record

United Health Products Updates FDA and OTC Markets Applications

United Health Products provides update on FDA and OTC Markets applications, including successful testing results for CelluSTAT Hemostatic Gauze. Progress towards FDA approval and OTCQB uplisting signals positive development for the company.

This news matters as it highlights the progress of United Health Products in meeting FDA requirements for its hemostatic gauze product. The successful completion of sterilization and biotoxicity tests is a significant step towards accessing the human surgical market. Investors and stakeholders will be monitoring the outcome of the FDA Premarket Approval and OTCQB uplisting applications.